CLEARMIND MEDICINE INC (CMND) Stock Income Statement
USA - NASDAQ:CMND - CA1850534027 - Common Stock
0.2164 USD
-0.06 (-21.85%)
0.2299 USD
+0.01 (+6.24%)
| TTM (2025-7-31) | 2024 (2024-10-31) | 2023 (2023-10-31) | 2022 (2022-10-31) | 2021 (2021-10-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | null | 0 | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 5.78M | 5.74M | 6.30M | 6.25M | 2.71M | |||
| Research and Development | 2.12M | 1.38M | 1.54M | 3.08M | 475.90K | |||
| Selling, General, and Administrative Expenses | 3.67M | 4.32M | 4.76M | 3.16M | 2.23M | |||
| Operating Income | -5.78M | -5.74M | -6.30M | -6.25M | -2.71M | |||
| Interest Income/Expense | 1.95M | 904.40K | -2.30M | -613.60K | -24.70K | |||
| Other Income/Expense | -65.80K | -36.20K | null | null | null | |||
| Non Recurring Items | null | null | 0 | 0 | -7.40K | |||
| Income Before Taxes | -3.89M | -4.88M | -8.60M | -6.87M | -2.74M | |||
| Income Tax | 168.30K | 378.00K | 17.40K | 29.90K | null | |||
| Net Income | -4.05M | -5.25M | -8.62M | -6.89M | -2.74M | |||
| EBITDA | -5.73M | -5.69M | -6.25M | -6.17M | -2.70M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.8604 | -1.695 | -42.576 | -159.1062 | -88.5884 | |||
| Non GAAP EPS | null | null | null | null | null | |||
| Statistics | ||||||||
All data in USD